Abstract
Systemic lupus erythematosus (SLE) disproportionally impacts women during their childbearing years. Thus, issues regarding birth control, fertility, pregnancy, and nursing commonly arise in the care of young women with SLE. For many years, contraceptive choices for SLE patients were limited due to concerns that hormone-containing contraceptives would increase disease activity. Pregnancy itself was thought to exacerbate disease activity, and patients were often counseled that they should avoid becoming pregnant. Medication use during pregnancy and nursing was likewise thought to be limited which further complicated the management of the pregnant lupus patient. Fortunately, the past two decades have brought us a better understanding of how SLE disease activity responds to pregnancy. Newer treatment regimens have improved disease outcome and enabled more patients to contemplate pregnancy and parenthood. This chapter will discuss contraception, fertility, pregnancy, and nursing in women with SLE.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Sources
Slater CA, Liang MH, McCune JW, Christman GM, Laufer MR. Preserving ovarian function in patients receiving cyclophosphamide. Lupus. 1999;8(1):3–10.
Bermas BL. Oral contraceptives in systemic lupus erythematosus—a tough pill to swallow? N Engl J Med. 2005;353:2602–4.
Van Nieuwenhoven ALV, Heineman MJ, Faas MM. The immunology of successful pregnancy. Hum Reprod Update. 2003;9(4):347–57.
Lund CJ, Donovan JC. Blood volume during pregnancy. Significance of plasma and red cell volumes. Am J Obstet Gynecol. 1967;98(3):394–403.
Marik PE, Plante LA. Venous thromboembolic disease and pregnancy. N Engl J Med. 2008;359(19):2025–33.
Heckman JD, Sassard R. Current concepts review. Musculoskeletal considerations in pregnancy. J Bone Joint Surg Am. 1994;76(11):1720–30.
Van den Broe NR, Letsky EA. Pregnancy and the erythrocyte sedimentation rate. BJOG. 2001;108(11):1164–7.
Ruiz-Irastorza G. Evaluation of systemic lupus erythematosus activity during pregnancy. Lupus. 2004;13(6):679–82.
Petri M, Howard D, Repke J, Goldman DW. The Hopkins Lupus Pregnancy Center: 1987–1991 update. Am J Reprod Immunol. 1992;28(3–4):188–91.
Izmirly PM, Kim MY, Llanos C, et al. Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine. Ann Rheum Dis. 2010;69:1827–30.
Sibai BM. Imitators of severe pre-eclampsia. Semin Perinatol. 2009;33(3):196–205.
Al Arfaj AS, Khalil N. Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia. Lupus. 2010;19(14):1665–73.
Smyth A, Oliveira HM, Lahr BD, et al. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol. 2010;5:2060–8.
Marker-Hermann E, Fischer-Betz R. Rheumatic diseases and pregnancy. Curr Opin Obstet Gynecol. 2010;22:458–65.
Ruiz-Irastorza G, Khamashta MA. Managing lupus patients during pregnancy. Best Pract Res Clin Rheumatol. 2009;23:575–82.
American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics. 2001;108(3):924–36.
Clouse ME, Magder L, Witter F, Petri M. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum. 2006;54(11):3640–7.
Ostensen M, Khamashta M, Lockshin M, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther. 2006;8(3):209.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. Baltimore: Williams and Wilkins; 2001.
Pyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology. 2000;62(6):385–92.
Amenti VT, Ahlswede KM, Ahlswede BA, Jarrell BE, Moritz MJ, Burke JF. National transplantation pregnancy registry-outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantation. 1994;57(4):502–6.
Donnenfeld AE, Pastuszak A, Noah JS, Schick B, Rose NC, Koren G. Methotrexate exposure prior to and during pregnancy. Teratology. 1994;49(2):79–81.
Koren G, Inoue M. Do tumor necrosis factor inhibitors cause malformations in humans? J Rheumatol. 2009;36(93):665–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media New York
About this chapter
Cite this chapter
Bermas, B.L. (2012). Systemic Lupus Erythematosus and Pregnancy. In: Schur, P., Massarotti, E. (eds) Lupus Erythematosus. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-1189-5_14
Download citation
DOI: https://doi.org/10.1007/978-1-4614-1189-5_14
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-1188-8
Online ISBN: 978-1-4614-1189-5
eBook Packages: MedicineMedicine (R0)